Having trouble accessing articles? Reset your cache.

Antisoma plunges after misses in AML

Antisoma plc (LSE:ASM) fell 4.03p (64%) to 2.22p on Monday after announcing that it discontinued development of acute myelogenous leukemia

Read the full 207 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE